Working together with

University of NC

Duke and UNC have collaborated to become one of the ten centers that are to receive a National Institute of Health (NIH) 5-year grant to conduct research and to provide diagnosis, counseling, medical care and education for Sickle Cell Disease and related disorders.

Duke Center of Human Genetics

The study outcome modifying genes in sickle cell disease is a collaborative effort between the Duke University Medical Center and the Duke University Center of Human Genetics. Marilyn J. Telen is the principal investigator. The UNC sickle cell center and the Emory sickle cell center are also participating in the study. The study is sponsored by the National Institutes of Health. Duke Center for Human Genetics and the Duke Comprehensive Sickle Cell Center hope that data gained from this research study will lead to better prevention and treatment of Sickle Cell Disease complications.

North Carolina's Community Programs

Duke Comprehensive Sickle cell center will continues to develop patient service materials, to help support effective community-based programs, and assist in coordination of evidence-based state-wide activities that benefit all sickle cell patients in North Carolina. Therefore the Center continues to closely with the educator-counselors of the NC Sickle Cell Syndrome Program, Operation Sickle Cell, Inc., and The Sickle Cell Anemia Foundation of the Piedmont.
The Center also provides leadership and support to the NC Sickle Cell Disease Consortium.